bullish
Pre-IPO MIXUE Group (PHIP Updates) - Some Points Worth the Attention
471 Views20 Feb 2025 00:55
MIXUE's supply chain advantages and franchise model give it a unique edge over peers, but it has reached growth ceiling in China. Despite concerns, MIXUE’s valuation should still be higher than peers
What is covered in the Full Insight:
- Introduction
- MIXUE's Supply Chain Advantages
- Franchise Model Analysis
- Market Expansion Challenges
- Valuation Insights and Conclusion
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Related Insights
More »- Mixue Group (2097 HK) - Updates on Valuation Outlook and Growth Forecast Based on 2024 Results
- Mixue Vs Guming: Valuation Premium. Comparing Earnings Growth in 2024
- HSCI Index Rebalance Preview: Three Hot Inclusions to Stock Connect in June
- MIXUE Group (2097.HK) - Updates on Performance Forecast and Valuation Outlook
- China Healthcare Weekly (Mar.9) - 11th VBP, PD-1/VEGF BsAb Outlook, MIXUE's Stunning IPO Debut
Trending Collections
More »Trending Insights
More »- Merger Arb Mondays (09 June) - Mayne, Tam Jai, OneConnect, Toyota Industries, Makino, Fuji Corp
- Curator's Cut: The Next Labubu, Crypto Equities and Tracking APAC Buybacks
- [Japan M&A] Private Co Takeout of Fuji Corp (7605 JP) - A Done Deal
- Taiwan Top 50 ETF Rebalance: Elite Materials Added (But Bigger Sell Flows Elsewhere)
- Fuji Corp (7605 JP): Usami Koyu’s JPY2,830 Tender Offer Is Light but Done
Top Unpaywalled Insights
More »- Curator's Cut: The Next Labubu, Crypto Equities and Tracking APAC Buybacks
- [IO Technicals 2025/23] Bearish Momentum Persists
- VEON US: Pakistan Towers Sale Frees Capital for Digital Growth in Core Market Ahead of Ukraine IPO
- Advanced Look: Navigating the New Macro Landscape Through Quantitative Alpha Generation Strategies
- [IO Technicals 2025/22] Bearish Momentum Strengthens
Discussions
(Paid Plans Only)
Top 5%
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
Price Chart(Sign Up to Access)
- China Healthcare Weekly (Mar.2) - NewCo Model, Pfizer-Summit Deal, Henlius to Enter HK Stock Connect02 Mar 2025
- Pre-IPO MIXUE Group (2097.HK) - The IPO Is Attractively Priced24 Feb 2025
- China Healthcare Weekly (Feb.23)-Ping An Good Doctor Shares Surge, China Healthcare Has Bottomed Out23 Feb 2025
- Pre-IPO MIXUE Group (PHIP Updates) - Some Points Worth the Attention20 Feb 2025
- Pre-IPO MIXUE Group Update - The Snow King Is Facing Headwinds18 Feb 2025
- Pre-IPO Guming Holdings - Thoughts on Valuation10 Feb 2025
- Pre-IPO MIXUE Group - The Snow King Opens up a Lot More Room for Imagination than Expected10 Jan 2024
x